PedAM
Pediatric Disease Annotations & Medicines
| Disease | diabetes mellitus, insulin-dependent |
| Symptom | C0730345|microalbuminuria |
| Sentences | 29 |
| PubMedID- 23524911 | Protein intake in relation to risk of hypertension and microalbuminuria in patients with type 1 diabetes: the eurodiab prospective complications study. |
| PubMedID- 21726280 | We studied the relationship between exercise intensity, measured as maximal oxygen consumption (vo(2)max), and microalbuminuria in patients with type 1 diabetes mellitus patients. |
| PubMedID- 20199663 | Zerbini et al have recently shown that renal hypertrophy predicts microalbuminuria in patients with type 1 diabetes and normal renal function . |
| PubMedID- 21871097 | Progression to microalbuminuria in patients with type 1 diabetes: a seven-year prospective study. |
| PubMedID- 22533828 | Mild enlargement of the juxtaglomerular apparatus has been reported in insulin-dependent diabetes mellitus patients with microalbuminuria . |
| PubMedID- 26064987 | Demonstrated that an increase in systolic blood pressure during sleep preceded the development of microalbuminuria in patients with type 1 diabetes . |
| PubMedID- 22359892 | Results of the present study showed that lower levels of hdl2 cholesterol were associated with microalbuminuria in patients with type 1 diabetes. |
| PubMedID- 26207222 | In both type one and two diabetic patients, results of the clinical investigations three years after the procedure clearly revealed that there were no significant differences in the incidence or progression of diabetes micro vascular complications in patients who had either undergone fetal liver-derived cell suspension allotransplantation or received placebo compared to the baseline (table 2).table 2presence of retinopathy,neuropathy and microalbuminuria in patients with type 1 diabetes at the baseline and 3 years following the interventiontype 1 diabetesretinopathy (baseline)totalp-valuerethinopathy (3rd year)totalp-valuenormalpdrnormalnpdrgroupsinterventioncount130130.999b111120.999b(%)100.0%.0%100.0%91.7%8.3%100.0%placebocount1611712012(%)94.1%5.9%100.0%100.0%.0%100.0%totalcount2913023124(%)96.7%3.3%100.0%95.8%4.2%100.0%neuropathy (basal)totalp-valueneuropathy (3rd year)totalp-valueno_neurophathyneuropathy+no_neurophathyneuropathy+groupsinterventioncount121130.433b102120.478b(%)92.3%7.7%100.0%83.3%16.7%100.0%placebocount1701712012(%)100.0%.0%100.0%100.0%.0%100.0%totalcount2913022224(%)96.7%3.3%100.0%91.7%8.3%100.0%microalbominuria (baseline)totalp-valuemicroalbominuria (3rd year)totalp-valueno albominuriamicroalbominuria+no albominuriamicroalbominuria+groupsinterventioncount121130.844a120120.307a(%)92.3%7.7%100.0%100.0%.0%100.0%placebocount1611711112(%)94.1%5.9%100.0%91.7%8.3%100.0%totalcount2823023124(%)93.3%6.7%100.0%95.8%4.2%100.0%apearson chi-square.bfisher’s exact test. |
| PubMedID- 23754672 | The aim of this study was to demonstrate that neutrophil gelatinase-associated lipocalin (ngal) increased before the onset of microalbuminuria in patients with type 1 diabetes mellitus (t1dm), representing an important biochemical parameter with high sensitivity and specificity to make a precocious diagnosis of "normoalbuminuric" diabetic nephropathy (dn). |
| PubMedID- 19908023 | Using state of the art methods in prediction modelling, we therefore developed and externally validated a clinical prediction rule for estimating risk of progression to microalbuminuria in patients with type 1 diabetes. |
| PubMedID- 24802730 | Metabolic control and its variability are major risk factors for microalbuminuria in children with type 1 diabetes. |
| PubMedID- 21747824 | microalbuminuria in humans with type 1 diabetes (t1d) is associated with increased urinary excretion of megalin, as well as many megalin ligands, including vitamin-d-binding protein (vdbp). |
| PubMedID- 25767718 | Relationships between annual antibiotic purchase rates and progression of microalbuminuria in patients with type 1 diabetes. |
| PubMedID- 23920083 | (17) had type 1 diabetes, those with microalbuminuria or other complications at baseline were excluded. |
| PubMedID- 25853247 | Conclusions: ivccm detects early small fibre damage in the absence of retinopathy or microalbuminuria in patients with type 1 diabetes. |
| PubMedID- 21335371 | Conclusions: in the current study, a1c variability was an independent variable that added to the effect of a1c on the risk for microalbuminuria in youth with type 1 diabetes, a population highly vulnerable to vascular complications. |
| PubMedID- 25340133 | In type 1 diabetes with microalbuminuria, systemic blood pressure will begin to increases, although it may still be within normal range. |
| PubMedID- 23858799 | The effect of metabolic and hormonal parameters on microalbuminuria in adolescents with type 1 diabetes mellitus. |
| PubMedID- 20138413 | Background: urinary markers were tested as predictors of macroalbuminuria or microalbuminuria in patients with type 1 diabetes. |
| PubMedID- 20188385 | Conversely, levels are elevated in type 1 diabetes mellitus (t1dm) and associated with microalbuminuria and diabetic nephropathy. |
| PubMedID- 23659818 | Development of a cpg to identify microalbuminuria in children with type 1 diabetes is discussed. |
| PubMedID- PMC4428784 | In this study we have analyzed the hba1c variability to investigate the influence on progression of microalbuminuria in patients with type 1 diabetes. |
| PubMedID- 23151275 | Previous reports indicated that inflammation is a protracted process, occurring from the early stages of nephropathy (egfr >90ml/min/1.73m2 and microalbuminuria) in patients with type 1 diabetes (t1d). |
| PubMedID- 26239688 | Urinary microrna profiling predicts the development of microalbuminuria in patients with type 1 diabetes. |
| PubMedID- PMC4428812 | In pediatric type 1 diabetes patients without microalbuminuria, the urinary vdbp loss was increased proportionally with the urinary macr. |
| PubMedID- 24103009 | Aims: to clarify whether urinary type iv collagen-to-creatinine ratio is a predictor for the incidence of microalbuminuria in patients with type 1 diabetes. |
| PubMedID- 25064124 | Conclusions/interpretation: our data suggest that high levels of the complement activating molecule h-ficolin are associated with an increased risk of future progression to microalbuminuria in patients with newly diagnosed type 1 diabetes. |
| PubMedID- 24009298 | The decline in prevalence of diabetic nephropathy and microalbuminuria in women with type 1 diabetes is in line with a general trend toward lower prevalence of diabetic nephropathy in the danish diabetic population (32). |
| PubMedID- 22322918 | Conclusions/interpretation: together with other studies, these data suggest that creatinine- or cystatin-based estimates of gfr do not predict the development of microalbuminuria in patients with type 1 diabetes. |
Page: 1